Physician profile
Richard E May
NPI 1073879896
$8,984.09
in general payments reported to CMS, 2019-2025
35 companies · $2,594 in 2025
The $2,594 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $544 · 2021: $537 · 2022: $1,418 · 2023: $1,870 · 2024: $1,887 · 2025: $2,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,501 · Travel and Lodging: $668 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,501.41 |
| Travel and Lodging | $667.75 |
| Education | $181.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,633.85 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,407.33 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $730.36 | 2020-2025 | |
| Noah Medical Corporation | $667.75 | 2025 | Galaxy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $667.30 | 2022-2025 | Ofev, Spiriva Respimat, Jascayd |
| Abbvie INC. | $524.98 | 2022-2025 | |
| Insmed, INC. | $484.84 | 2020-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $426.66 | 2020-2025 | Dupixent |
| Philips North America LLC | $378.26 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mallinckrodt Hospital Products INC. | $205.15 | 2022-2023 | Acthar |
| Sanofi-Aventis U.S. LLC | $181.98 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $148.01 | 2021-2025 | Glassia |
| Mylan Specialty L.P. | $147.27 | 2022-2024 | Yupelri |
| Amgen INC. | $124.42 | 2022-2025 | Tezspire |
| Allergan, INC. | $122.56 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $118.54 | 2021-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $116.92 | 2024-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $115.17 | 2024-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $111.10 | 2019-2024 | Belsomra, Keytruda, Capvaxive |
| Vifor Pharma, INC. | $100.24 | 2024-2025 | Zemaira |
| Baxter Healthcare | $99.33 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Teva Pharmaceuticals USA, INC. | $83.28 | 2021-2022 | |
| Intuitive Surgical, INC. | $78.98 | 2024 | |
| Pfizer INC. | $47.35 | 2023-2025 | |
| Inspire Medical Systems, INC. | $45.96 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $44.89 | 2022-2024 | |
| Viatris Specialty LLC | $38.01 | 2025 | Yupelri |
| Pulmonx Corporation | $21.53 | 2022 | |
| Alk-Abello, INC | $18.88 | 2025 | Grastek, Ragwitek, Odactra |
| Lilly USA, LLC | $18.40 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $15.82 | 2023 | Sunosi |
| Novartis Pharmaceuticals Corporation | $15.71 | 2020 | |
| Alexion Pharmaceuticals, INC. | $15.68 | 2023 | Ultomiris |
| Harmony Biosciences LLC | $14.19 | 2020 | |
| Azurity Pharmaceuticals, INC. | $13.39 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.